US$ 24.95
sunrise glp 1 AUSactive CEO Ken Griffin appeared on this morning, speaking about the importance of weight-bearing exercise for people using GLP-1 medications to help reduce muscle loss and support bone πΈNew GLP-1 Pricing is here!
Description
David Kessler says the new weight-loss drugs are a powerful tool to fight obesity
The growing popularity of GLP-1 receptor agonistsincluding Ozempic and Wegovy from Novo Nordisk, and Mounjaro and Zepbound from Eli Lillyhas added fuel to an already fiery debate over the governments

Chronic diseases such as obesity and diabetes, cardiovascular and inflammatory bowel diseases (IBD) share common features in their pathology
Your body depends on glucose for energy